Genotype Guided Comparison of Clopidogrel and Prasugrel Outcomes Study "GeCCO"


Phase N/A Results N/A

Summary of Purpose

The primary objective of this trial is to demonstrate the non-inferiority of clopidogrel compared to prasugrel over 6 months in cardiovascular disease patients when the clopidogrel cohort is limited to the estimated 70% of the population that are CYP2C19 extensive metabolizers. This protocol will examine the comparative... Trial Stopped: Administrative reasons

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 May 2012.

1 Oct 2009 14 Oct 2009 1 May 2012 1 May 2012 1 May 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample


Not available